Charles River Laboratories International, Inc. Common Stock (CRL)
150.33
-17.16 (-10.25%)
NYSE · Last Trade: Aug 6th, 7:05 PM EDT
Charles River lifts earnings guidance after Q2 beat, citing biotech demand stability, solid DSA performance, and easing regulatory headwinds.
Via Benzinga · August 6, 2025
Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top S&P500 gainers and losers in today's session.
Via Chartmill · August 6, 2025
Lab services company Charles River Laboratories (NYSE:CRL) reported Q2 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $1.03 billion. Its non-GAAP profit of $3.12 per share was 24.6% above analysts’ consensus estimates.
Via StockStory · August 6, 2025
Lab services company Charles River Laboratories (NYSE:CRL)
will be announcing earnings results this Wednesday before market open. Here’s what to look for.
Via StockStory · August 4, 2025
Curious about the top performers within the S&P500 index one hour before the close of the markets on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Via Chartmill · July 24, 2025
Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.
Via Chartmill · July 24, 2025
Via Benzinga · July 24, 2025
Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Thursday. Discover the gap up and gap down stocks in the S&P500 index.
Via Chartmill · July 24, 2025
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday.
Via Chartmill · July 22, 2025
Shares of lab services company Charles River Laboratories (NYSE:CRL)
jumped 7.5% in the morning session after the company announced a plasmid DNA manufacturing agreement with Elly's Team, a parent-led foundation working to find a cure for a rare genetic disorder.
Via StockStory · July 22, 2025
Let's delve into the developments on the US markets in the middle of the day on Tuesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.
Via Chartmill · July 22, 2025
Via Benzinga · July 22, 2025
Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.
Via Chartmill · July 22, 2025
Via Benzinga · July 21, 2025
Stay informed about the performance of the S&P500 index in the middle of the day on Monday. Uncover the top gainers and losers in today's session for valuable insights.
Via Chartmill · July 21, 2025
Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Monday to uncover the stocks that are gapping in the S&P500 index.
Via Chartmill · July 21, 2025
The bid to set clear working rules for the cryptocurrency industry in the U.S. got a booster pill Thursday as the House of Representatives passed key pieces of legislation.
Via Benzinga · July 17, 2025
A number of stocks fell in the morning session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada.
Via StockStory · July 11, 2025
Curious about the market action on Friday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.
Via Chartmill · July 11, 2025
Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.
Via Chartmill · July 10, 2025
Via Benzinga · July 9, 2025
ARK Invest CEO Cathie Wood agrees with Fundstrat Global Advisors Head of Research Tom Lee and has likened the Circle (NYSE:CRL) IPO to a pivotal moment in the crypto industry, suggesting that institutional investors can no longer ignore the co
Via Benzinga · July 9, 2025
Seasoned investor Cathie Wood on Monday praised an analyst from Ark Invest’s Digital Assets team for their successful take on Circle Internet Group, Inc. (NYSE:CRL) from a month ago.
Via Benzinga · July 8, 2025